Literature DB >> 16220091

Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis.

Janet R Casey1, Michael E Pichichero.   

Abstract

OBJECTIVE: To compare bacterial and clinical cure rates in patients with group A streptococcal (GAS) tonsillopharyngitis treated with oral beta-lactam or macrolide antibiotics for 4-5 days versus 10-day comparators.
METHODS: Medline, Embase, reference lists and abstract searches were used to identify available publications. Trials were included if there was bacteriologic confirmation of GAS tonsillopharyngitis, random assignment to antibiotic therapy for a beta-lactam or macrolide antibiotic of a shortened course versus a 10-day comparator and assessment of bacteriologic outcome using a throat culture.
RESULTS: Twenty-two trials involving 7470 patients were included in 4 separate analyses. Trials were grouped by a short course of cephalosporins (n = 14), macrolides (other than azithromycin) (n = 6) and penicillin (n = 2). Cephalosporin trials were further grouped by the comparator, penicillin or the same cephalosporin. Short course cephalosporin treatment was superior for bacterial cure rate compared with 10 days of penicillin [odds ratio (OR), 1.47; 95% confidence interval (CI), 1.06-2.03]. For trials with short course macrolide therapy, OR = 0.79 (95% CI 0.59-1.06) neither the macrolides nor the 10-day comparators. Short course penicillin therapy was inferior in achieving bacterial cure versus 10 days of penicillin, OR = 0.29 (95% CI 0.13-0.63). Clinical cure rates mirrored bacteriologic cure rates.
CONCLUSION: Superior cure rates can be achieved with shortened courses of cephalosporin therapy, but 5 days is inferior to 10 days of penicillin treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220091     DOI: 10.1097/01.inf.0000180573.21718.36

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  What is the optimal duration of antibiotic therapy?

Authors:  John Paul
Journal:  BMJ       Date:  2006-06-10

2.  Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration.

Authors:  Erika M C D'Agata; Pierre Magal; Damien Olivier; Shigui Ruan; Glenn F Webb
Journal:  J Theor Biol       Date:  2007-08-25       Impact factor: 2.691

3.  Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

4.  Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.

Authors:  George Dimopoulos; Dimitrios K Matthaiou; Drosos E Karageorgopoulos; Alexandros P Grammatikos; Zoe Athanassa; Matthew E Falagas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.

Authors:  Hiroyuki Iuchi; Junichiro Ohori; Satoshi Kiyama; Naoko Imuta; Junichiro Nishi; Yuichi Kurono; Masaru Yamashita
Journal:  BMC Microbiol       Date:  2021-05-14       Impact factor: 3.605

6.  Evaluation of Rational Drug Use for Acute Pharyngitis Associated with the Incidence and Prevalence of the Disease at Two Community Health Centers in Indonesia.

Authors:  Cindra T Yuniar; Kusnandar Anggadiredja; Alfi N Islamiyah
Journal:  Sci Pharm       Date:  2017-04-28

Review 7.  Treatment Challenges of Group A Beta-hemolytic Streptococcal Pharyngo-Tonsillitis.

Authors:  Itzhak Brook
Journal:  Int Arch Otorhinolaryngol       Date:  2016-06-03

8.  Amoxicillin effect on bacterial load in group A streptococcal pharyngitis: comparison of single and multiple daily dosage regimens.

Authors:  Akihiro Nakao; Ken Hisata; Makoto Fujimori; Nobuaki Matsunaga; Mitsutaka Komatsu; Toshiaki Shimizu
Journal:  BMC Pediatr       Date:  2019-06-21       Impact factor: 2.125

9.  Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A beta-Hemolytic Streptococcus pharyngitis in Children.

Authors:  Hideaki Kikuta; Mutsuo Shibata; Shuji Nakata; Tatsuru Yamanaka; Hiroshi Sakata; Kouji Akizawa; Kunihiko Kobayashi
Journal:  Int J Pediatr       Date:  2009-03-05

Review 10.  Upper respiratory tract infections (including otitis media).

Authors:  Peter S Morris
Journal:  Pediatr Clin North Am       Date:  2009-02       Impact factor: 3.278

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.